Latest News for: prosetin

Edit

ProJenX Announces a Development Update for Prosetin, a First-in-Class, CNS-Penetrant MAP4K Inhibitor

PR Newswire 16 Jun 2026
PRO-101 was designed to evaluate the safety, tolerability, pharmacokinetics (PK), and target engagement of prosetin ... Today's data answers that question, supporting continued evaluation of prosetin for ALS." ... ABOUT PROSETIN.
  • 1
×